{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:02:41Z","timestamp":1790402561832,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["psychiatricnursing.org","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Psychiatric Nursing"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.apnu.2024.12.005","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T01:57:50Z","timestamp":1736042270000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and safety evaluation of olanzapine treatment for schizophrenia patients: A retrospective data analysis"],"prefix":"10.1016","volume":"54","author":[{"given":"Jingyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apnu.2024.12.005_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1408876","article-title":"Growing evidence of pharmacotherapy effectiveness in managing attention-deficit\/hyperactivity disorder in young children with or without autism spectrum disorder: A minireview","volume":"15","author":"Alsayouf","year":"2024","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.apnu.2024.12.005_bb0010","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5\u2122","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.apnu.2024.12.005_bb0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.apnu.2024.12.005_bb0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1016\/j.apnu.2024.12.005_bb0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5498\/wjp.v14.i6.794","article-title":"Association of serum interleukin-6 with negative symptoms in stable early-onset schizophrenia","volume":"14","author":"Chen","year":"2024","journal-title":"World J Psychiatry."},{"key":"10.1016\/j.apnu.2024.12.005_bb0030","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2147\/NDT.S209284","article-title":"A commentary on the efficacy of olanzapine for the treatment of schizophrenia: The past, present, and future","volume":"15","author":"Citrome","year":"2019","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.apnu.2024.12.005_bb0035","series-title":"ECDEU assessment manual for psychopharmacology","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"issue":"20","key":"10.1016\/j.apnu.2024.12.005_bb0040","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.apnu.2024.12.005_bb0045","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study","volume":"157","author":"Henderson","year":"2000","journal-title":"The American Journal of Psychiatry"},{"issue":"10","key":"10.1016\/j.apnu.2024.12.005_bb0050","first-page":"1171","article-title":"Retrospective studies and chart reviews","volume":"49","author":"Hess","year":"2004","journal-title":"Respiratory Care"},{"issue":"6","key":"10.1016\/j.apnu.2024.12.005_bb0055","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5498\/wjp.v14.i6.884","article-title":"Computerized cognitive remediation therapy on cognitive impairment and social function in patients with chronic schizophrenia","volume":"14","author":"Hu","year":"2024","journal-title":"World Journal of Psychiatry"},{"key":"10.1016\/j.apnu.2024.12.005_bb0060","article-title":"Characterizing defective lipid metabolism in the lateral septum of mice treated with olanzapine: Implications for its side effects","volume":"15","author":"Huang","year":"2024","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.apnu.2024.12.005_bb0065","article-title":"Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders","volume":"7","author":"Ibragimov","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl. 12","key":"10.1016\/j.apnu.2024.12.005_bb0070","first-page":"5","article-title":"The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: Methods, commentary, and summary","volume":"64","author":"Kane","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.apnu.2024.12.005_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1016\/j.apnu.2024.12.005_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/schbul\/sbx090","article-title":"Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: A meta-analysis of prospective and retrospective cohort studies","volume":"44","author":"Kishimoto","year":"2018","journal-title":"Schizophrenia Bulletin"},{"issue":"9657","key":"10.1016\/j.apnu.2024.12.005_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.apnu.2024.12.005_bb0090","first-page":"101","article-title":"Sex differences in schizophrenia, a review of the literature","author":"Leung","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"12","key":"10.1016\/j.apnu.2024.12.005_bb0095","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.apnu.2024.12.005_bb0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.62.9.975","article-title":"Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review","volume":"62","author":"Marshall","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.apnu.2024.12.005_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia\u2014An overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.apnu.2024.12.005_bb0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.2051-5545.2008.tb00182.x","article-title":"Early intervention in psychosis: Concepts, evidence and future directions","volume":"7","author":"McGorry","year":"2008","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.apnu.2024.12.005_bb0115","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1016\/j.apnu.2024.12.005_bb0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"Gorham DR the brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"3","key":"10.1016\/j.apnu.2024.12.005_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"9305","key":"10.1016\/j.apnu.2024.12.005_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","article-title":"Generation of allocation sequences in randomised trials: Chance, not choice","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.apnu.2024.12.005_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"27","key":"10.1016\/j.apnu.2024.12.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035663","article-title":"Comparative efficacy and safety of olanzapine and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.apnu.2024.12.005_bb0145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis","volume":"27","author":"Zhu","year":"2017","journal-title":"European Neuropsychopharmacology"}],"container-title":["Archives of Psychiatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941724002280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941724002280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:13:35Z","timestamp":1739463215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883941724002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":29,"alternative-id":["S0883941724002280"],"URL":"https:\/\/doi.org\/10.1016\/j.apnu.2024.12.005","relation":{},"ISSN":["0883-9417"],"issn-type":[{"value":"0883-9417","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety evaluation of olanzapine treatment for schizophrenia patients: A retrospective data analysis","name":"articletitle","label":"Article Title"},{"value":"Archives of Psychiatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apnu.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}